PDII PDI, Inc. featured news, full reports, and detailed charts
PDI, Inc. (PDII) Wrap Up:
We are a leading provider of contract sales teams to pharmaceutical companies, offering a range of sales support services designed to achieve their strategic and financial product objectives. In addition to contract sales teams, we also provide marketing research, physician interaction and medical education programs. Our services offer customers a range of promotional and educational options for the commercialization of their products throughout their lifecycles, from development through maturity. We provide innovative and flexible service offerings designed to drive our customers’ businesses forward and successfully respond to a continually changing market. Our services provide a vital link between our customers and the medical community through the communication of product information to physicians and other healthcare professionals for use in the care of their patients. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f13%2f0001054102-08-000005.html#FIS_BUSINESS"PDI Inc. (PDII:NASDAQ)
Snapshot of PDI Inc. (PDII)
|
OPEN
$4.00
|
PREVIOUS CLOSE
$4.05
|
|
|
DAY HIGH
$4.10
|
DAY LOW
$3.94
|
|
|
52 WEEK HIGH
02/20/09 - $6.25
|
52 WEEK LOW
03/12/09 - $2.80
|
|
|
MARKET CAP
58.1M
|
AVERAGE VOLUME 3 mo
63.1K
|
|
|
DILUTED EPS TTM
$-2.27
|
SHARES OUTSTANDING
14.2M
|
|
|
PDII Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
PDII Top Compensated Officers
Executives, Board Directors
Key developments for PDI Inc. (PDII)
PDI Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported net revenue of $21,041,000 compared to $24,496,000 for the same period a year ago. Operating loss was $4,566,000 compared to $9,589,000 for the same period a year ago. Loss before income tax was $4,536,000 compared to $8,960,000 for the same period a year ago. Net loss was $4,562,000 compared to $9,004,000 for the same period a year ago. Diluted loss per share of common stock was $0.32 compared to $0.63 for the same period a year ago. On an adjusted basis, this excludes the loss from the product commercialization contract, facilities realignment and severance charges, the operating loss for the third quarter of 2009 declined 38% to $2.7 million from $4.4 million in 2008. For the nine months, the company reported net revenue of $60,863,000 compared to $87,124,000 for the same period a year ago. Operating loss was $14,829,000 compared to $19,197,000 for the same period a year ago. Loss before income tax was $14,635,000 compared to $16,618,000 for the same period a year ago. Net loss was $15,112,000 compared to $17,541,000 for the same period a year ago. Diluted loss per share of common stock was $1.06 compared to $1.23 for the same period a year ago.
PDI Inc. expected to Report Fiscal Year 2009 Results on March 8, 2010. This event was calculated by Capital IQ (Created on November 5, 2009).
PDI Inc. and Physicians Interactive Inc. have entered into a strategic alliance to collaborate and deliver the first integrated network of digital sales and marketing solutions. These products will drive expanded reach and revenue for life sciences customers, while increasing the level of service, access and value to physicians. By way of this unique collaboration, life sciences companies will be able to provide a comprehensive, optimized mix of personal delivery services, such as PDI's field sales, peer-based, and call-center services to physicians who benefit from physical outreach. Physicians Interactive will augment PDI's personal efforts, and extend services to those physicians challenged by location, time, or preference with range of on-demand digital services. These offerings include mobile-based point-of-care decision support tools, electronic sampling and patient assistance programs, as well as interactive online education. The partnership will significantly expand customer reach beyond that of traditional sales and marketing solutions. The combined networks and behavioral databases will connect life sciences companies with over one million health care professionals worldwide.
PDII Competitors
| Company | Last | Change |
| inVentiv Health Inc | $16.10 USD | -0.11 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | PDII | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.7x |
|
| Price/Book | 0.6x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
PDII |
||
PDII transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About PDI, Inc.
More news for PDII
PDI INC Files SEC form 8-K, Change in Directors or Principal Officers
Show all filings for PDI INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for PDI INC 15-Sep-2009Change in Directors or Principal Officers Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for tr...Click here to read the whole Article (external link)
PDI, Inc. to Hold Third Quarter 2009 Financial Results Conference Call on Thursday, November 5, 2009
Copyright © 2009 Yahoo! All rights reserved. Privacy Policy - Terms of Service - Copyright Policy - Report Problems Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quote data delayed 15 minutes for Nasdaq, NYSE and Amex. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Yahoo! is not an investment adviser and does not provide, endorse or review any information or data contained herein....Click here to read the whole Article (external link)
Q3 2009 PDI, Inc. Earnings Release - After Market Close
Earnings Announcements for Thursday, November 5CompanySymbolTimeConferenceCall21st Century HoldingTCHC2:00 pm ET3I INFRASTRUCTURE3IN.LBefore Market OpenAbiomed, Inc.ABMDBefore Market OpenListenABOVENET INCABVTAfter Market CloseListenAbraxis BioScience, Inc.ABIIBefore Market OpenListenAccelrys Inc.ACCLAfter Market CloseListenACI Worldwide, Inc.ACIWBefore Market OpenACTIONS SEMICONDUCTOR CO LTDACTSAfter Market CloseActive Biotech ABACTI.STTime Not SuppliedActivision Blizzard, Inc.ATVIAfter Market CloseAdecco SAAHEXF.PK01:00 am ETAinsworth Lumber Company Ltd.ANS.TOAfter Market CloseAir MethodsAIRMAfter Market CloseAker ASAAKERTime Not SuppliedALAMOS GOLD INCAGI.TOBefore Market OpenAlaska Communications Systems GroupALSKAfter Market CloseAlexandria Real Estate...Click here to read the whole Article (external link)
PDI and Physicians Interactive Partner To Provide Integrated, Personal and Digital Solutions to Life Sciences Companies
SADDLE RIVER, N.J., Nov. 2 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII - News), a leading provider of sales and marketing support to U.S. health care companies, and Physicians Interactive, the leading provider of mobile reference and digital sales and marketing services to life sciences companies, have entered into a strategic alliance to collaborate and deliver the first integrated network of digital sales and marketing solutions. These products will drive expanded reach and revenue for life sciences customers, while increasing the level of service, access and value to physicians. By way of this unique collaboration, life sciences companies will be able to provide a comprehensive, optimized mix of personal delivery services, such as PDI's field sales, peer-based, and call-center services to physicians who benefit from physical outreach. Physicians Interactive will augment PDI's personal efforts, and extend services to those physicians challenged by location, time, or preference with an exciting range of on-demand digital services. These offerings include leading mobile-based point-of-care decision support tools, electronic sampling and patient assistance programs, as well as interactive online education.The partnership will significantly expand customer reach beyond that of traditional sales and marketing solutions. The combined networks and behavioral databases will connect life sciences companies with over one million health care professionals worldwide."Physicians Interactive is a respected leader in the digi...Click here to read the whole Article (external link)
PDI Reports 2009 Third Quarter Financial Results
SADDLE RIVER, N.J., Nov. 5 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII - News), a leading provider of sales and marketing support to U.S. pharmaceutical companies, today reported financial and operational results for the third quarter ended September 30, 2009.Commenting on today's announcement, Nancy Lurker, Chief Executive Officer of PDI, Inc., stated, "Third quarter 2009 revenues of $21.0 million were lower than last year by approximately 14%. Higher revenue in our Marketing Services business was offset by reductions in our Sales Services business. Despite lower revenue, this year's third quarter operating loss was reduced by more than 50% compared to last year. The reduction in operating loss was in large part due to the absence of the impact of the product commercialization contract that was in effect in 2008. However, on an adjusted basis, excluding the loss from the product commercialization contract, facilities realignment and severance charges, the third quarter 2009 operating loss is still 38% lower than last year, in large part due to our ongoing cost reduction initiatives and higher revenue in Marketing Services."While revenues were down in the third quarter compared to last year, as expected, they were up almost 30% over the second quarter of this year. However, the current economic climate coupled with pharmaceutical industry consolidation and downsizing, has led to a delay in gaining significant new business as many pharmaceutical companies have slowed their sales force initiatives...Click here to read the whole Article (external link)
PDI INC. 2009 Third Quarter Financial Results Call scheduled for 4:30 pm ET today
Call DetailsPDI INC. 2009 Third Quarter Financial ResultsThu, Nov 5, 2009, 4:30 pm EasternAbout PDI, Inc. (NasdaqGM:PDII)PDI, Inc. provides outsourced pharmaceutical sales and marketing services to biopharmaceutical and life sciences industries in the United States. It offers a range of sales support services, as well as marketing research, physician interaction, and medical education programs. The companys services offer customers a range of promotional options for the commercialization of their products throughout their lifecycles, from development through maturity. PDI focuses primarily on product detailing, which involves a sales representative meeting face-to-face with targeted physicians and other healthcare decision makers to provide a technical review of the product being promoted. It also offers a portfolio of expanded sales services, which include talent acquisition services, pulsing teams, and vacancy coverage services. In addition, the company provides performance sales team, as well as a shared sales team that provides a face-to-face selling resource to those customers who want an alternative to a dedicated team. PDIs marketing services include creation, designing, and implementation of promotional peer interactive programming through a number of different venues, including teleconferences, dinner meetings, Web casts, satellite, and other alternative media. These programs offer various services, including strategic design, tactical execution, technology support, audience recruitment, moderator services, and thought leader management. Further, the company provides pharmaceutical marketing research services, including studies to identify the impact business strategy, profile, positioning, message, execution, implementation, and post implementation for a product. Additionally, it develops and executes continuing medical education se...Click here to read the whole Article (external link)
PDI INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Show all filings for PDI INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for PDI INC 5-Nov-2009Results of Operations and Financial Condition, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for infor...Click here to read the whole Article (external link)
PDI INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
New Star Analyst Rankings for PDI, Inc.
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Copyright © 1999-2003, StarMine Corp. All rights reserved.StarMine Corp. derives analyst ratings from estimate and recommendation data supplied by Thomson Financial.Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and...Click here to read the whole Article (external link)
